consumer safety

The Dark Side of IndiaMART: Compromising Global Healthcare and Safety

IndiaMART, a major online marketplace, is under scrutiny for its role in the sale of pharmaceuticals. The platform’s lack of stringent verification processes and focus on bulk sales have led to the distribution of tainted medications, raising significant global health concerns. Incidents involving suppliers like QP Pharmachem highlight the dangers of unregulated pharmaceutical sales, including the risk of contamination with harmful substances. This article delves into the implications for global healthcare, the erosion of trust in legitimate Indian pharmacies, and the influence of regulatory bodies like LegitScript, emphasizing the need for stricter oversight and consumer awareness.

Read more

The FDA’s Hypocrisy: Blocking Access to WHO-Approved Pharmaceuticals While Allowing Unregulated Research Chemicals

The FDA, tasked with protecting public health, faces criticism for its double standards in regulatory enforcement. While it blocks WHO-approved pharmaceuticals from India, limiting access to affordable medications, it allows the unregulated proliferation of research chemicals like SARMs within the U.S. This selective enforcement extends to dietary supplements and food additives, posing significant risks to consumers. This article calls for accountability and meaningful reform to ensure the FDA prioritizes public health over corporate interests.

Read more